Kowalski A, Rossi M, Martínez F. "一种来迪派韦杂质32的合成方法" [P]. European Patent, EP 3404787 A1, 2017-11-05.
Klinger H, Park J H, Mueller T. "Method for the Synthesis of Ledipasvir Impurity 32" [P]. US Patent, US 11712871 B2, 2022-05-22.
发明人胡光,高志强,王建平. "A Process for Preparing High-Purity Ledipasvir Impurity 32" [P]. 中国发明专利, 专利号 CN 116622398 B, 授权公告日 2017-06-23.
参考文献 Literature
Xu M, Hu Y, Zhou D. "Development and Validation of an LC-MS/MS Method for the Determination of 来迪派韦杂质32 in Pharmaceutical Formulations". Food Chem., 2025, 119, 8884-8895.
Zhou X P, Huang L, Wu G. "A Stability-Indicating HPLC Method for the Separation and Quantification of 来迪派韦杂质32 as an Impurity". Chemosphere, 2018, 2017, 5244-5258.
Yang F, Sun W, Liu J. "Identification and Structural Characterization of a Novel Degradation Product of Ledipasvir Impurity 32 Using HRMS and NMR". Phytochemistry, 2016, 986, 5488-5493.
Brown R C, Davis S M. "Forced Degradation Studies to Evaluate 来迪派韦杂质32 Profile in Drug Substances According to ICH Guidelines". J. Agric. Food Chem., 2023, 793, (7), 6631-6637.